Skip to content
CODX·Nasdaq·US

Co-Diagnostics

Co-Diagnostics is a molecular diagnostics company that develops, manufactures, and markets PCR-based testing technologies and related reagents. Its products and platform are used for infectious disease testing and other nucleic-acid detection applications.

Thematic Position

CODX

Relationship Groups

Customers1
Competitors3

Relationship details are part of the Pro plan.

Ended Relationships

6 ended relationships · Ended relationships are part of the Pro plan.

Management Perspective on Regulatory & Geopolitical Developments

regulatory approvalmarket authorization
FDA 510(k) clearance required before Co-Dx PCR platform can be sold in U.S.
SEC 10-QAug 13, 2026

The full regulatory passage is part of the Pro plan.

7 more · Regulatory and geopolitical insights are part of the Pro plan.